Submit a Request

Topic: Treatment

Brief: Tobacco and Opioids

The brief explores the connection between tobacco use and opioid addiction, highlighting how smoking may increase the risk of opioid misuse and how addressing tobacco dependence can improve substance use recovery outcomes. It emphasizes the need for integrated treatment approaches in substance use disorder programs, including tobacco cessation interventions, to enhance recovery success. The document also outlines policy and healthcare strategies to support dual cessation efforts, such as insurance coverage, clinical screening, staff training, and tobacco-free campus policies.

How HIPAA Allows Doctors to Respond to the Opioid Crisis

This resource explains how HIPAA allows healthcare professionals to share health information with a patient’s loved ones during emergencies or dangerous situations, such as an opioid overdose, when doing so is in the patient’s best interest. It clarifies that health providers can disclose information to family and caregivers without patient consent if the patient is incapacitated or poses a serious and imminent threat to their health. Additionally, it outlines limitations on sharing information for patients who have decision-making capacity and recognizes state laws regarding personal representatives who have authority over a patient’s health information.

How HIPAA Helps Family and Friends Stay Connected with Loved Ones Who Have a Substance Use Disorder, including Opioid Abuse, or a Mental or Behavioral Health Condition 

This resource explains how HIPAA allows healthcare providers to share necessary health information with family and friends of individuals with substance use disorders (including opioid abuse) or mental health conditions when it is in the patient’s best interest. It outlines how providers can notify loved ones in emergencies, share relevant treatment details for caregiving purposes, and grant full access to personal representatives who have legal decision-making authority.

When can I obtain treatment information about my loved one? (decision chart)

The HIPAA Decision Tree for Adult Patients is a guide that helps determine when a healthcare provider can share treatment information about an adult patient under HIPAA regulations, based on factors such as the patient’s decision-making ability, the requester’s role in their care, and potential risks to the patient.

Federal Guidelines for Opioid Treatment Programs (2024)

This manual provides guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administration and use; medical and clinical provisions and practices; certification and accreditation; and the importance of practitioner judgment in providing care.

FindTreatment.gov

The confidential and anonymous resource for persons seeking treatment for mental and substance use disorders in the United States and its territories. Available in Spanish.

Improving African American Retention in Mental Health and Substance Use Disorder Treatment

This 2-hour self-paced course from the African American Behavioral Health Center of Excellence is for mental health and substance use disorder practitioners and primary care physicians who seek to provide culturally responsive care. Its focus is on helping the workforce understand the presence and impact of implicit racial bias in health care and mental health treatment.

Medications for Opioid Use Disorder (MOUD): The Basics

This online video course provides a foundational understanding of Medications for Opioid Use Disorder (MOUD), exploring their benefits and applications in treating opioid addiction. Participants will learn about specific medications such as Buprenorphine, Methadone, and Naltrexone, along with strategies to engage clients in treatment discussions and empower informed decision-making. Presented by Krista Hales, DBH LADC-S, this training is ideal for professionals seeking to enhance their knowledge and skills in opioid addiction treatment.

Treatment of Opioid Use Disorder Before, During, and After Pregnancy

The CDC page outlines the importance of medication-assisted treatment (MAT) for opioid use disorder (OUD) during pregnancy, emphasizing methadone and buprenorphine as effective options to improve maternal and neonatal outcomes. It also highlights the need for comprehensive care, including mental health support, to reduce relapse risks and manage withdrawal symptoms in newborns.